Fox Fern ADHD Clinic

Fox Fern ADHD Clinic A neurodiverse psychiatry provider treating neurodiverse patients in the Seattle area.

02/09/2025

Another Barrier to ADHD Care:
A proposed DEA rule change will limit psychiatry prescribers to issuing only 50% of ADHD medications by telehealth, aiming to prevent misuse. But for rural patients, it means losing vital access to care.

The appointment button is now live on our website!https://www.foxfernadhdclinic.comWe’re now accepting new patient appoi...
01/03/2023

The appointment button is now live on our website!

https://www.foxfernadhdclinic.com

We’re now accepting new patient appointments starting January 9th 2023 so go grab a spot!

Right now it looks like Premera insurance will be accepted by January 9th but Regence is dragging their credentialing feet and so we’ll keep you updated on that one.

Progress is quickly being made on the www.foxfernadhdclinic.com website!The button to make an appointment should be acti...
12/29/2022

Progress is quickly being made on the www.foxfernadhdclinic.com website!

The button to make an appointment should be active in just a few days!

On track for our Soft Open on January 9th 2023.

Russell A. Barkley, PhD, is an internationally recognized authority on ADHD in children and adults who has dedicated his...
12/24/2022

Russell A. Barkley, PhD, is an internationally recognized authority on ADHD in children and adults who has dedicated his career to widely disseminating science-based information about ADHD. Dr. Barkley is a Clinical Professor of Psychiatry at the Virginia Treatment Center for Children and Virginia Commonwealth University Medical Center in Richmond, Virginia.

Citation: Inserro, Allison. (2018, January 14). "Psychologist Barkley Says Life Expectancy Slashed in Worst Cases for Those With ADHD."
Retrieved Sept. 24, 2019, from
https://www.ajmc.com/conferences/apsard-2018/psychologist-barkley-says-life-expectancy-slashed-in-worst-cases-forthose-with-adhd.

“40.2 % of those with ASD experienced ADHD in their lifetime.”Rong, Ying, et al. "Prevalence of attention-deficit/hypera...
12/05/2022

“40.2 % of those with ASD experienced ADHD in their lifetime.”

Rong, Ying, et al. "Prevalence of attention-deficit/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis." Research in Autism Spectrum Disorders 83 (2021): 101759.

A large study of more than 150,000 adults demonstrated a lack of association between stimulant use and incidence of hear...
11/30/2022

A large study of more than 150,000 adults demonstrated a lack of association between stimulant use and incidence of heart attack, sudden cardiac death, and stroke.

“In our population-based cohort of more than 440,000 young and middle-aged adults, including more than 150,000 users of ADHD medications identified through filled prescriptions, we found no evidence of an increased risk of MI, SCD, or stroke associated with current use compared to non-use or remote use of ADHD medications. We also found little support for an increased risk for any specific medication or with longer duration of current use. Results were similar when users were restricted to new users. Rate ratios did not appear to be influenced by prior cardiovascular disease or by prior non-ADHD psychiatric conditions. They also were similar across age groups.”

Adults who have ADHD but do not know it are at much higher risk than the general population for serious problems. Severe...
11/29/2022

Adults who have ADHD but do not know it are at much higher risk than the general population for serious problems. Severe stress, depression, and anxiety disorders often occur when ADHD goes undiagnosed.

Adults with untreated ADHD are:

8 times more likely to have a sleep disorder.
7.5 times more likely to have treatment-resistant depression.
3.7 times more likely to have an anxiety disorder.

ADHD genetic studies show that recurrence risk to first-degree relatives is about five times higher than the population ...
11/28/2022

ADHD genetic studies show that recurrence risk to first-degree relatives is about five times higher than the population prevalence.

People with childhood ADHD are nearly twice as likely to develop a substance use disorder compared to individuals who do...
11/28/2022

People with childhood ADHD are nearly twice as likely to develop a substance use disorder compared to individuals who don’t have childhood ADHD.

ADHD patients treated with stimulant medications experience a 60% reduction in substance abuse disorders compared to those who were not treated with stimulant medication.

Additionally, research suggests a 10% reduction in substance use disorders for every year of ADHD treatment, especially for patients who start at an earlier age.

Adults who have ADHD but do not know it are at much higher risk than the general population for serious problems. Severe...
11/10/2022

Adults who have ADHD but do not know it are at much higher risk than the general population for serious problems. Severe stress, depression, and anxiety disorders often occur when ADHD goes undiagnosed.

Adults with untreated ADHD are –
8 times more likely to have a sleep disorder.
7.5 times more likely to have treatment-resistant depression.
3.7 times more likely to have an anxiety disorder.

Treating ADHD is safe for both adults and children.A pivotal study published in 2019 showed that “ADHD treatment may add...
11/09/2022

Treating ADHD is safe for both adults and children.
A pivotal study published in 2019 showed that “ADHD treatment may add an average of nine to thirteen years to the lifespan of children and adults diagnosed with ADHD.”

Address

Bellevue, WA

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm

Alerts

Be the first to know and let us send you an email when Fox Fern ADHD Clinic posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram